Tag: FV Pharma

October 22, 2018

FSD Pharma Signs Binding LOI to Acquire Therapix Biosciences, a NASDAQ Traded Pharmaceutical Company Focusing on the Development of Cannabinoid-Based Treatments, to Create Medical Cannabis Industry Innovator

FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE:HUGE) (OTCQB:FSDDF) (FRA:0K9) announced today the signing of a binding letter of...
October 11, 2018

FSD Pharma Featured on CNBC in Anticipation of October 17

In a recent article, major US broadcaster CNBC, reported an overview of the Canadian market as it compares to legalization...
September 19, 2018

FSD Pharma Announces Upgraded Listing to OTCQB Venture Market

FSD Pharma Inc, (CSE:HUGE) announced today that its subordinate voting shares have been upgraded to a listing on the OTCQB...
September 13, 2018

FSD Pharma to Expand into Jamaican Market and Introduce FSD Jamaica

FSD Pharma Inc, (CSE:HUGE) is pleased to announce that it intends to launch a strategic partnership into the Jamaican cannabis...
September 7, 2018

FSD Pharma Congratulates High Tide Ventures for Selection as Supplier to Ontario Cannabis Retail Corporation

FSD Pharma Inc, (CSE:HUGE) ("FSD Pharma" or "FSD") today congratulated High Tide Ventures Inc. ("High Tide") for the selection of...
August 21, 2018

FSD Pharma Completes Harvest and Microbial Testing of First Lot

FSD Pharma Inc, (CSE:HUGE) is pleased to announce that its wholly-owned subsidiary, FV Pharma Inc. ("FV Pharma"), a licensed cannabis...
May 2, 2015

FSD Pharma provides update on status of 2018 year-end filings

FSD Pharma Inc. (CSE:HUGE) (OTC:FSDDF) (FRA:0K9) ("FSD Pharma" or "FSD") announces this morning that it has been delayed in filing...